lobbying_activities: 1954105

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1954105	7628f526-60b0-405f-8a83-a93e5e98429b	Q1	AMERICAN PUBLIC HEALTH ASSOCIATION	3173	AMERICAN PUBLIC HEALTH ASSOCIATION	2017	first_quarter	CAW	Oppose H.R. 5, the Regulatory Accountability Act of 2017. Oppose the Regulations from the Executive in Need of Scrutiny, or REINS, Act and the Midnight Rules Relief Act. Oppose H.R. 998, the SCRUB Act; H.R. 1004, the Regulatory Integrity Act; and H.R. 1009, the OIRA Insight, Reform, and Accountability Act. Oppose the EPA Science Advisory Board Reform Act of 2017 and the Honest and Open New EPA Science Treatment Act of 2017. Oppose H.J. Res. 36, a resolution of disapproval using the Congressional Review Act to permanently the Bureau of Land Management from reducing methane leaks from the oil and gas industries. Oppose the Ozone Standards Implementation Act of 2016.Office of Management and Budget raising Oppose executive order 13771 Reducing Regulation and Controlling Regulatory Costs over concerns that it could jeopardize public regulations that safeguard safety and health.	Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),President of the U.S.,SENATE,White House Office		38000	0	0	2017-04-17T12:37:31.267000-04:00